The present application discloses novel prodrugs of substituted 3-(4-hydroxy-phenyl)-indolin-2-one compounds (oxindole compounds), and the use of such compounds for the preparation of a medicament for the treatment of cancer in a mammal. The prodrug compounds are of the formula (I).
本申请公开了取代的3-(
4-羟基苯基)-
吲哚啉-2-酮化合物(氧
吲哚化合物)的新型前药,以及利用这些化合物制备哺乳动物癌症治疗药物的用途。前药化合物的
化学式为(I)。